Neuroscience
Allopurinol may cut risk for neurodegenerative diseases
Xanthine dehydrogenase/oxidase blockers may reduce the risk for neurodegenerative diseases, according to a study published online May 17 in PLOS ONE.
May 19, 2023
0
4
News tagged with allopurinol
Cardiology
Allopurinol does not improve cardiovascular outcomes in ischemic heart disease patients
The gout medicine allopurinol has failed to reduce the primary endpoint of nonfatal myocardial infarction, nonfatal stroke or cardiovascular death in patients with ischemic heart disease, according to late breaking research ...
Aug 29, 2022
0
0
Medications
Allopurinol not tied to higher mortality for patients with gout and chronic kidney disease
(HealthDay)—For patients with gout and chronic kidney disease (CKD), no associations with increased mortality were seen for allopurinol initiation, achieving target serum urate (SU) levels, or allopurinol dose escalation, ...
Jan 25, 2022
0
6
Medications
FAST study finds no increased risk of cardiovascular events with febuxostat as compared with allopurinol for gout
A major new study examining the relative safety of medicines for the treatment of gout will be presented at the American College of Rheumatology Convergence conference and will be published in The Lancet.
Nov 10, 2020
0
5
Diseases, Conditions, Syndromes
Drug used to slow kidney disease found to be ineffective
Following a major clinical trial, clinicians find the drug allopurinol does not prevent worsening of kidney disease.
Jun 25, 2020
1
38
Cardiology
Heart, kidney disease risk factors for adverse effects from gout medication
Heart disease is an independent risk factor for severe adverse skin reactions in patients taking allopurinol, found a study published in CMAJ (Canadian Medical Association Journal).
Sep 30, 2019
0
0
Diseases, Conditions, Syndromes
Allopurinol linked to reduced risk for CKD stage ≥3 in gout
(HealthDay)—For patients with gout, allopurinol is associated with a reduced risk for developing chronic kidney disease stage ≥3, according to a study published online Oct. 8 in JAMA Internal Medicine.
Oct 25, 2018
0
1
Diseases, Conditions, Syndromes
Gout drug may protect against chronic kidney disease
The drug allopurinol used to manage gout may offer protection against the development of kidney disease, according to a new study.
Oct 8, 2018
0
1
Arthritis & Rheumatism
Allopurinol dose escalation for gout doesn't improve mortality
(HealthDay)—Allopurinol dose escalation is not associated with reductions in mortality risk among patients with gout, according to a study published in the August issue of Arthritis & Rheumatology.
Sep 20, 2018
0
0
Diseases, Conditions, Syndromes
Major cardiovascular study of gout patients has unexpected finding
A large study of cardiovascular events in gout patients taking one of two medications to prevent excess build-up of uric acid has found that one of the drugs, febuxostat, increased the risk of death for those with heart disease, ...
Mar 12, 2018
0
2
